Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - NAVIDEA BIOPHARMACEUTICALS, INC.Financial_Report.xls
10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_10k.htm
EX-3.1 - EXHIBIT 3.1 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex3-1.htm
EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex32-1.htm
EX-23.1 - EXHIBIT 23.1 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex23-1.htm
EX-10.5 - EXHIBIT 10.5 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex10-5.htm
EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex32-2.htm
EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex24-1.htm
EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC.v303459_ex31-2.htm

Exhibit 21.1

 

Subsidiaries of Navidea Biopharmaceuticals, Inc.

 

Subsidiaries  Jurisdiction of Incorporation   Percentage Owned by Registrant 
Cardiosonix Ltd.   Israel    100%
Cira Biosciences, Inc.   Delaware, USA    90%
RIGSTech I Corporation   Delaware, USA    100%
Navidea Biopharmaceuticals Limited   United Kingdom    100%